Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective and Molecular Biomarker-Based Evaluation of Cardiac Side Effects in Patients With Early-Stage Breast Cancer Receiving Systemic Therapy: A Single-Center Observational Cohort Study

NCT07588425 is registered in ClinicalTrials.gov with Fatih GURLER as lead sponsor.

NCT NCT07588425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07588425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective and Molecular Biomarker-Based Evaluation of Cardiac Side Effects in Patients With Early-Stage Breast Cancer Receiving Systemic Therapy: A Single-Center Observational Cohort Study
Lead sponsor
Fatih GURLER
Phase
Observational
Overall status
Recruiting
Start date
May 11, 2026
Completion date
March 30, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer (early breast cancer), cancer therapy-related cardiac dysfunction, cardiotoxicity